• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PT. CIBA VISION BATAM O2 OPTIX; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PT. CIBA VISION BATAM O2 OPTIX; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Lot Number 31256060
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Blurred Vision (2137)
Event Date 07/01/2017
Event Type  Injury  
Manufacturer Narrative
The actual complaint product was not returned for evaluation.The device history record and sterilization record for this lot have been reviewed and found to be in compliance.There was no nonconformity or deviations during the manufacturing process which related to the nature of the complaint.The root cause could not be determined.(b)(4).
 
Event Description
As initially reported by a family member, a consumer had a two-month history of blurry vision, with contact lenses moving upwards in the eye ¿as if it was with fungus.¿ the family member reported that the consumer was involved in a car accident, for which no injury was reported, attributed to the blurry vision; the consumer was also involved in a subsequent motorcycle accident on (b)(6) 2017, for which he was hospitalized, also attributed to the blurry vision that the consumer experienced.Further information received from both the initial reporter and the consumer stated that the consumer had struck both a motor vehicle and a cow with his motorcycle, due to reported visual issues.It was confirmed that the consumer was released from the hospital on (b)(6)2017, being treated with saline solution and unspecified medications.Additional information has been requested but not yet received.
 
Manufacturer Narrative
Two opened samples in a flat case were returned for evaluation and were found to meet manufacturing specifications.The device history record and sterilization record for this lot have been reviewed and found to be in compliance.The manufacturing review did not indicate that this complaint was due to the manufacturing process.No complaint or manufacturing trend was identified.The root cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
O2 OPTIX
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
PT. CIBA VISION BATAM
beringin kav. #204 batamindo
industrial park muka kuning
pulau batam 29433
ID  29433
Manufacturer (Section G)
PT. CIBA VISION BATAM
beringin kav. #204 batamindo
industrial park muka kuning
pulau batam 29433
ID   29433
Manufacturer Contact
nadia bailey
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8176152230
MDR Report Key6935361
MDR Text Key89152657
Report Number9681121-2017-00070
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K033919
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Reporter Occupation Patient Family Member or Friend
Type of Report Initial,Followup
Report Date 11/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/31/2021
Device Lot Number31256060
Other Device ID Number000000000010010899-155628100
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/09/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received10/15/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/27/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age19 YR
-
-